HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

adonirubin

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Ishibashi, Takashi: 1 article (01/2013)
2.	Maoka, Takashi: 1 article (01/2013)
3.	Ohmori, Aya: 1 article (01/2013)
4.	Osawa, Ayako: 1 article (01/2013)
5.	Shindo, Kazutoshi: 1 article (01/2013)
6.	Suzuki, Nobutaka: 1 article (01/2013)
7.	Tokuda, Harukuni: 1 article (01/2013)
8.	Yasui, Hiroyuki: 1 article (01/2013)

Related Diseases

1.

Neoplasms (Cancer)

01/01/2013 - "Anti-oxidative, anti-tumor-promoting, and anti-carcinogenic activities of adonirubin and adonixanthin."
01/01/2013 - "Furthermore, adonirubin and adonixanthin exhibited an inhibitory effect on Epstein-Barr virus early antigen activation in Raji cells and carcinogensis of mouse skin tumors initiated by 7,12-dimethylbenz[a]anthracene and promoted by 12-O-tetradecanoylphorbol-13-acetate."
01/01/2013 - "Anti-oxidative, anti-tumor-promoting, and anti-carcinogenic activities of adonirubin and adonixanthin, which are biosynthetic intermediates from β-carotene to astaxanthin, were investigated. "

Related Drugs and Biologics

1.	Carotenoids (Carotene)
2.	adonixanthin
3.	anthracene
4.	Epstein-Barr virus early antigen
5.	astaxanthine (astaxanthin)